Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective

The continuing emergence of multi-drug resistant pathogens has sparked an interest in seeking alternative therapeutic options. Antimicrobial combinatorial therapy is one such avenue. A number of studies have been conducted, involving combinations of bacteriocins with other antimicrobials, to circumv...

Full description

Bibliographic Details
Main Authors: Harsh Mathur, Des Field, Mary C. Rea, Paul D. Cotter, Colin Hill, R. Paul Ross
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-06-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmicb.2017.01205/full
id doaj-575051311f8542849d222ca11329fd3f
record_format Article
spelling doaj-575051311f8542849d222ca11329fd3f2020-11-24T23:37:45ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2017-06-01810.3389/fmicb.2017.01205281736Bacteriocin-Antimicrobial Synergy: A Medical and Food PerspectiveHarsh Mathur0Harsh Mathur1Des Field2Des Field3Mary C. Rea4Mary C. Rea5Paul D. Cotter6Paul D. Cotter7Colin Hill8Colin Hill9R. Paul Ross10R. Paul Ross11Teagasc Food Research Centre, MooreparkCork, IrelandAPC Microbiome Institute, University College CorkCork, IrelandAPC Microbiome Institute, University College CorkCork, IrelandSchool of Microbiology, University College CorkCork, IrelandTeagasc Food Research Centre, MooreparkCork, IrelandAPC Microbiome Institute, University College CorkCork, IrelandTeagasc Food Research Centre, MooreparkCork, IrelandAPC Microbiome Institute, University College CorkCork, IrelandAPC Microbiome Institute, University College CorkCork, IrelandSchool of Microbiology, University College CorkCork, IrelandAPC Microbiome Institute, University College CorkCork, IrelandSchool of Microbiology, University College CorkCork, IrelandThe continuing emergence of multi-drug resistant pathogens has sparked an interest in seeking alternative therapeutic options. Antimicrobial combinatorial therapy is one such avenue. A number of studies have been conducted, involving combinations of bacteriocins with other antimicrobials, to circumvent the development of antimicrobial resistance and/or increase antimicrobial potency. Such bacteriocin-antimicrobial combinations could have tremendous value, in terms of reducing the likelihood of resistance development due to the involvement of two distinct mechanisms of antimicrobial action. Furthermore, antimicrobial synergistic interactions may also have potential financial implications in terms of decreasing the costs of treatment by reducing the concentration of an expensive antimicrobial and utilizing it in combination with an inexpensive one. In addition, combinatorial therapies with bacteriocins can broaden antimicrobial spectra and/or result in a reduction in the concentration of an antibiotic required for effective treatments to the extent that potentially toxic or adverse side effects can be reduced or eliminated. Here, we review studies in which bacteriocins were found to be effective in combination with other antimicrobials, with a view to targeting clinical and/or food-borne pathogens. Furthermore, we discuss some of the bottlenecks which are currently hindering the development of bacteriocins as viable therapeutic options, as well as addressing the need to exercise caution when attempting to predict clinical outcomes of bacteriocin-antimicrobial combinations.http://journal.frontiersin.org/article/10.3389/fmicb.2017.01205/fullbacteriocinsantibiotic resistancesynergystressorspathogensantimicrobials
collection DOAJ
language English
format Article
sources DOAJ
author Harsh Mathur
Harsh Mathur
Des Field
Des Field
Mary C. Rea
Mary C. Rea
Paul D. Cotter
Paul D. Cotter
Colin Hill
Colin Hill
R. Paul Ross
R. Paul Ross
spellingShingle Harsh Mathur
Harsh Mathur
Des Field
Des Field
Mary C. Rea
Mary C. Rea
Paul D. Cotter
Paul D. Cotter
Colin Hill
Colin Hill
R. Paul Ross
R. Paul Ross
Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
Frontiers in Microbiology
bacteriocins
antibiotic resistance
synergy
stressors
pathogens
antimicrobials
author_facet Harsh Mathur
Harsh Mathur
Des Field
Des Field
Mary C. Rea
Mary C. Rea
Paul D. Cotter
Paul D. Cotter
Colin Hill
Colin Hill
R. Paul Ross
R. Paul Ross
author_sort Harsh Mathur
title Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
title_short Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
title_full Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
title_fullStr Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
title_full_unstemmed Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
title_sort bacteriocin-antimicrobial synergy: a medical and food perspective
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2017-06-01
description The continuing emergence of multi-drug resistant pathogens has sparked an interest in seeking alternative therapeutic options. Antimicrobial combinatorial therapy is one such avenue. A number of studies have been conducted, involving combinations of bacteriocins with other antimicrobials, to circumvent the development of antimicrobial resistance and/or increase antimicrobial potency. Such bacteriocin-antimicrobial combinations could have tremendous value, in terms of reducing the likelihood of resistance development due to the involvement of two distinct mechanisms of antimicrobial action. Furthermore, antimicrobial synergistic interactions may also have potential financial implications in terms of decreasing the costs of treatment by reducing the concentration of an expensive antimicrobial and utilizing it in combination with an inexpensive one. In addition, combinatorial therapies with bacteriocins can broaden antimicrobial spectra and/or result in a reduction in the concentration of an antibiotic required for effective treatments to the extent that potentially toxic or adverse side effects can be reduced or eliminated. Here, we review studies in which bacteriocins were found to be effective in combination with other antimicrobials, with a view to targeting clinical and/or food-borne pathogens. Furthermore, we discuss some of the bottlenecks which are currently hindering the development of bacteriocins as viable therapeutic options, as well as addressing the need to exercise caution when attempting to predict clinical outcomes of bacteriocin-antimicrobial combinations.
topic bacteriocins
antibiotic resistance
synergy
stressors
pathogens
antimicrobials
url http://journal.frontiersin.org/article/10.3389/fmicb.2017.01205/full
work_keys_str_mv AT harshmathur bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT harshmathur bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT desfield bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT desfield bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT marycrea bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT marycrea bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT pauldcotter bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT pauldcotter bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT colinhill bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT colinhill bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT rpaulross bacteriocinantimicrobialsynergyamedicalandfoodperspective
AT rpaulross bacteriocinantimicrobialsynergyamedicalandfoodperspective
_version_ 1725519330084388864